1. Home
  2. CRBP vs FNWD Comparison

CRBP vs FNWD Comparison

Compare CRBP & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • FNWD
  • Stock Information
  • Founded
  • CRBP 2009
  • FNWD 1994
  • Country
  • CRBP United States
  • FNWD United States
  • Employees
  • CRBP N/A
  • FNWD N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • FNWD Savings Institutions
  • Sector
  • CRBP Health Care
  • FNWD Finance
  • Exchange
  • CRBP Nasdaq
  • FNWD Nasdaq
  • Market Cap
  • CRBP 114.8M
  • FNWD 137.3M
  • IPO Year
  • CRBP N/A
  • FNWD N/A
  • Fundamental
  • Price
  • CRBP $9.50
  • FNWD $32.00
  • Analyst Decision
  • CRBP Strong Buy
  • FNWD Buy
  • Analyst Count
  • CRBP 10
  • FNWD 1
  • Target Price
  • CRBP $53.22
  • FNWD $34.00
  • AVG Volume (30 Days)
  • CRBP 91.8K
  • FNWD 24.4K
  • Earning Date
  • CRBP 11-06-2025
  • FNWD 10-23-2025
  • Dividend Yield
  • CRBP N/A
  • FNWD 1.50%
  • EPS Growth
  • CRBP N/A
  • FNWD N/A
  • EPS
  • CRBP N/A
  • FNWD 1.24
  • Revenue
  • CRBP N/A
  • FNWD $63,780,000.00
  • Revenue This Year
  • CRBP N/A
  • FNWD N/A
  • Revenue Next Year
  • CRBP $220.04
  • FNWD $7.77
  • P/E Ratio
  • CRBP N/A
  • FNWD $25.74
  • Revenue Growth
  • CRBP N/A
  • FNWD N/A
  • 52 Week Low
  • CRBP $4.64
  • FNWD $26.12
  • 52 Week High
  • CRBP $56.93
  • FNWD $33.50
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 49.85
  • FNWD 64.93
  • Support Level
  • CRBP $9.42
  • FNWD $30.73
  • Resistance Level
  • CRBP $9.73
  • FNWD $32.63
  • Average True Range (ATR)
  • CRBP 0.51
  • FNWD 0.76
  • MACD
  • CRBP -0.08
  • FNWD -0.06
  • Stochastic Oscillator
  • CRBP 15.33
  • FNWD 65.65

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

Share on Social Networks: